Extensive Submacular Hemorrhage following Intravitreal Ranibizumab for Small Occult Choroidal Neovascular Membrane

Purpose Although intravitreal ranibizumab represents an established therapeutic approach for exudative age-related macular degeneration (AMD), the possible occurrence of adverse events remains under ongoing research. The purpose of this report is to present an incidence of an extensive submacular he...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of ophthalmology 2011-09, Vol.21 (5), p.665-667
Hauptverfasser:	Rouvas, Alexandras, Petrou, Petros, Vergados, loannis, Theodossiadis, Georgios, Theodossiadis, Panagiotis
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Angiogenesis Inhibitors - administration & dosage Angiogenesis Inhibitors - adverse effects Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal, Humanized Choroidal Neovascularization - drug therapy Female Fluorescein Angiography Humans Incidence Intravitreal Injections Macula Lutea Macular Degeneration - drug therapy Ranibizumab Retinal Hemorrhage - chemically induced Retinal Hemorrhage - diagnosis Tomography, Optical Coherence Visual Acuity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!